Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,147 | -17,548 | -13,428 | -8,747 | -4,322 |
| Depreciation Amortization | 40 | 152 | 113 | 82 | 35 |
| Accounts payable and accrued liabilities | -872 | -857 | -902 | -1,189 | -1,166 |
| Other Working Capital | -1,734 | -867 | -1,242 | -1,702 | -1,147 |
| Other Operating Activity | 1,149 | 2,189 | 1,885 | 1,974 | 1,487 |
| Operating Cash Flow | $-9,565 | $-16,931 | $-13,573 | $-9,582 | $-5,114 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -2 | -2 | N/A | N/A |
| Investing Cash Flow | $N/A | $-2 | $-2 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 165 | 165 | N/A | N/A |
| Common Stock Issued | 1 | 22,734 | 14,034 | 6,027 | 0 |
| Financing Cash Flow | $1 | $22,898 | $14,198 | $6,027 | $0 |
| Beginning Cash Position | 13,860 | 7,894 | 7,894 | 7,894 | 7,894 |
| End Cash Position | 4,296 | 13,860 | 8,517 | 4,339 | 2,780 |
| Net Cash Flow | $-9,564 | $5,966 | $624 | $-3,555 | $-5,114 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,565 | -16,931 | -13,573 | -9,582 | -5,114 |
| Capital Expenditure | N/A | -2 | -2 | N/A | N/A |
| Free Cash Flow | -9,565 | -16,933 | -13,575 | -9,582 | -5,114 |